Dr Reddy’s To Market Prestige's Trastuzumab Across Latin America And Southeast Asia
Proposed Herceptin Biosimilar Has Several Global Partners Primed For Commercialization
Prestige BioPharma has made the latest commercialization partnership for its proposed trastuzumab biosimilar, with Dr Reddy’s now in place to market the drug across select nations in Latin America and Southeast Asia.
